217 related articles for article (PubMed ID: 29480173)
1. Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study.
Falsetti L; Viticchi G; Buratti L; Grigioni F; Capucci A; Silvestrini M
J Alzheimers Dis; 2018; 62(2):713-725. PubMed ID: 29480173
[TBL] [Abstract][Full Text] [Related]
2. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.
Viticchi G; Falsetti L; Buratti L; Sajeva G; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2017; 59(1):67-75. PubMed ID: 28582863
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
5. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
6. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.
Ferrari C; Lombardi G; Polito C; Lucidi G; Bagnoli S; Piaceri I; Nacmias B; Berti V; Rizzuto D; Fratiglioni L; Sorbi S
J Alzheimers Dis; 2018; 61(2):785-791. PubMed ID: 29226870
[TBL] [Abstract][Full Text] [Related]
8. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
Proietti M; Calvieri C; Malatino L; Signorelli S; Corazza GR; Perticone F; Vestri AR; Loffredo L; Davì G; Violi F; Basili S;
Atherosclerosis; 2015 Feb; 238(2):350-5. PubMed ID: 25555267
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
[TBL] [Abstract][Full Text] [Related]
10. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
12. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Cheng YC; Huang YC; Liu HC
Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
14. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
[TBL] [Abstract][Full Text] [Related]
16. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.
de Oliveira FF; Pereira FV; Pivi GAK; Smith MC; Bertolucci PHF
Int J Neurosci; 2018 May; 128(5):472-476. PubMed ID: 29064737
[TBL] [Abstract][Full Text] [Related]
17. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
18. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
19. Framingham risk score can predict cognitive decline progression in Alzheimer's disease.
Viticchi G; Falsetti L; Buratti L; Boria C; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
Neurobiol Aging; 2015 Nov; 36(11):2940-2945. PubMed ID: 26279114
[TBL] [Abstract][Full Text] [Related]
20. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
